Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
28.49
-0.97 (-3.29%)
At close: May 28, 2025, 4:00 PM
29.91
+1.42 (4.98%)
After-hours: May 28, 2025, 7:52 PM EDT

Xenon Pharmaceuticals Statistics

Total Valuation

XENE has a market cap or net worth of $2.19 billion. The enterprise value is $1.50 billion.

Market Cap 2.19B
Enterprise Value 1.50B

Important Dates

The last earnings date was Monday, May 12, 2025, after market close.

Earnings Date May 12, 2025
Ex-Dividend Date n/a

Share Statistics

XENE has 76.73 million shares outstanding. The number of shares has increased by 11.90% in one year.

Current Share Class 76.73M
Shares Outstanding 76.73M
Shares Change (YoY) +11.90%
Shares Change (QoQ) +0.38%
Owned by Insiders (%) 0.14%
Owned by Institutions (%) 94.09%
Float 70.88M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 296.93
Forward PS n/a
PB Ratio 3.10
P/TBV Ratio 3.11
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 200.49
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 17.66, with a Debt / Equity ratio of 0.01.

Current Ratio 17.66
Quick Ratio 17.43
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -31.60% and return on invested capital (ROIC) is -22.74%.

Return on Equity (ROE) -31.60%
Return on Assets (ROA) -22.03%
Return on Invested Capital (ROIC) -22.74%
Return on Capital Employed (ROCE) -41.19%
Revenue Per Employee $22,936
Profits Per Employee -$768,948
Employee Count 327
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax -4.07M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -25.75% in the last 52 weeks. The beta is 1.22, so XENE's price volatility has been higher than the market average.

Beta (5Y) 1.22
52-Week Price Change -25.75%
50-Day Moving Average 33.58
200-Day Moving Average 38.38
Relative Strength Index (RSI) 31.64
Average Volume (20 Days) 1,363,200

Short Selling Information

The latest short interest is 3.47 million, so 4.52% of the outstanding shares have been sold short.

Short Interest 3.47M
Short Previous Month 3.58M
Short % of Shares Out 4.52%
Short % of Float 4.90%
Short Ratio (days to cover) 3.78

Income Statement

In the last 12 months, XENE had revenue of $7.50 million and -$251.45 million in losses. Loss per share was -$3.22.

Revenue 7.50M
Gross Profit -219.84M
Operating Income -293.00M
Pretax Income -199.34M
Net Income -251.45M
EBITDA -290.36M
EBIT -293.00M
Loss Per Share -$3.22
Full Income Statement

Balance Sheet

The company has $549.63 million in cash and $8.68 million in debt, giving a net cash position of $682.45 million or $8.89 per share.

Cash & Cash Equivalents 549.63M
Total Debt 8.68M
Net Cash 682.45M
Net Cash Per Share $8.89
Equity (Book Value) 703.96M
Book Value Per Share 9.19
Working Capital 533.51M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$196.85 million and capital expenditures -$2.93 million, giving a free cash flow of -$199.78 million.

Operating Cash Flow -196.85M
Capital Expenditures -2.93M
Free Cash Flow -199.78M
FCF Per Share -$2.60
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -3,906.60%
Pretax Margin -3,406.93%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

XENE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -11.90%
Shareholder Yield -11.90%
Earnings Yield -11.50%
FCF Yield -9.14%
Dividend Details

Analyst Forecast

The average price target for XENE is $54.82, which is 92.42% higher than the current price. The consensus rating is "Strong Buy".

Price Target $54.82
Price Target Difference 92.42%
Analyst Consensus Strong Buy
Analyst Count 11
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

XENE has an Altman Z-Score of 43.97 and a Piotroski F-Score of 1.

Altman Z-Score 43.97
Piotroski F-Score 1